Splenic vein thrombosis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]

Overview

There is insufficient evidence to recommend routine screening for splenic vein thrombosis. However, routine screening of portal and splenic vein thrombosis after elective splenectomy is warranted because it allows the initiation of anticoagulant therapy and avoid further life-threatening complications. The incidence of portal and splenic vein thrombosis is particularly high among patients operated on for lymphoma or with splenomegaly.

Screening

There is insufficient evidence to recommend routine screening for splenic vein thrombosis. However, routine screening of portal and splenic vein thrombosis after elective splenectomy is warranted because it allows to start anticoagulant therapy and avoid further life-threatening complications. The incidence of portal and splenic vein thrombosis is particularly high among patients operated on for lymphoma or with splenomegaly.^[1]^[2]^[3]

References

↑ Bouvier A, Gout M, Audia S, Chalumeau C, Rat P, Deballon O (2017). “[Routine screening of splenic or portal vein thrombosis after splenectomy]”. Rev Med Interne (in French). 38 (1): 3–7. doi:10.1016/j.revmed.2016.08.003. PMID 27639911.
↑ Valla D (2015). “Splanchnic Vein Thrombosis”. Semin Thromb Hemost. 41 (5): 494–502. doi:10.1055/s-0035-1550439. PMID 26080307.
↑ Gouin B, Robert-Ebadi H, Casini A, Beauverd Y, Fontana P, Righini M; et al. (2017). “[Splanchnic vein thrombosis]”. Rev Med Suisse. 13 (586): 2138–2143. PMID 29211374.

Overview